{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:17:34Z","timestamp":1790252254061,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.otc.2023.02.018","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:40:51Z","timestamp":1680536451000},"page":"611-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Future of Vestibular Schwannoma Management"],"prefix":"10.1016","volume":"56","author":[{"given":"Lindsay Scott","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina M.","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.otc.2023.02.018_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.otc.2015.02.005","article-title":"Neurofibromatosis type 2","volume":"48","author":"Slattery","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib2","first-page":"vdaa153","article-title":"New developments in neurofibromatosis type 2 and vestibular schwannoma","volume":"3","author":"Ren","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.otc.2023.02.018_bib3","doi-asserted-by":"crossref","first-page":"731441","DOI":"10.3389\/fonc.2021.731441","article-title":"Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/15384047.2014.972765","article-title":"Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells","volume":"16","author":"Dilwali","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"14","key":"10.1016\/j.otc.2023.02.018_bib6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2015.64.3817","article-title":"Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas","volume":"34","author":"Blakeley","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.otc.2023.02.018_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MAO.0000000000001026","article-title":"Neutrophil to Lymphocyte Ratio as a Predictive Marker of Vestibular Schwannoma Growth","volume":"37","author":"Kontorinis","year":"2016","journal-title":"Otol Neurotol"},{"issue":"6","key":"10.1016\/j.otc.2023.02.018_bib8","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.otc.2023.02.018_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2020.00191","article-title":"MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas","volume":"14","author":"Ren","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"2\u20133","key":"10.1016\/j.otc.2023.02.018_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12307-018-0216-2","article-title":"Cerebrospinal Fluid Hyaluronan and Neurofibromatosis Type 2","volume":"11","author":"Ariyannur","year":"2018","journal-title":"Cancer Microenviron"},{"issue":"6","key":"10.1016\/j.otc.2023.02.018_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.onc.1209849","article-title":"Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin","volume":"26","author":"Bai","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.otc.2023.02.018_bib12","doi-asserted-by":"crossref","first-page":"108985","DOI":"10.1016\/j.biopha.2019.108985","article-title":"Protein profiling of cerebrospinal fluid from patients undergoing vestibular schwannoma surgery and clinical significance","volume":"116","author":"Huang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"10.1016\/j.otc.2023.02.018_bib13","first-page":"5474","article-title":"Inner Ear Diagnostics and Drug Delivery via Microneedles","volume":"11","author":"Leong","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.otc.2023.02.018_bib14","doi-asserted-by":"crossref","first-page":"107761","DOI":"10.1016\/j.heares.2019.06.004","article-title":"A\u00a0novel microneedle device for controlled and reliable liquid biopsy of the human inner ear","volume":"381","author":"Early","year":"2019","journal-title":"Hear Res"},{"issue":"10","key":"10.1016\/j.otc.2023.02.018_bib15","doi-asserted-by":"crossref","first-page":"e35722","DOI":"10.2196\/35722","article-title":"Digital Biomarker-Based Studies: Scoping Review of Systematic Reviews","volume":"10","author":"Motahari-Nezhad","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.otc.2023.02.018_bib16","article-title":"Applications of deep learning methods in digital biomarker research using noninvasive sensing data","volume":"8","author":"Jeong","year":"2022","journal-title":"Digit Health"},{"issue":"11","key":"10.1016\/j.otc.2023.02.018_bib17","doi-asserted-by":"crossref","first-page":"e36696","DOI":"10.2196\/36696","article-title":"Health-Related Indicators Measured Using Earable Devices: Systematic Review","volume":"10","author":"Choi","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"issue":"24","key":"10.1016\/j.otc.2023.02.018_bib18","doi-asserted-by":"crossref","first-page":"e2521","DOI":"10.1212\/WNL.0000000000009490","article-title":"Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics","volume":"94","author":"Liu","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.otc.2023.02.018_bib19","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.otc.2023.02.018_bib20","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.7150\/thno.60582","article-title":"EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.otc.2023.02.018_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/lary.28822","article-title":"Intraoperative Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma","volume":"131","author":"Lee","year":"2021","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.otc.2023.02.018_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/stem.3353","article-title":"Human induced pluripotent stem cells and CRISPR\/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss","volume":"39","author":"Stojkovic","year":"2021","journal-title":"Stem Cell"},{"issue":"6","key":"10.1016\/j.otc.2023.02.018_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/stem.3346","article-title":"A\u00a0human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss","volume":"39","author":"Zine","year":"2021","journal-title":"Stem Cell"},{"key":"10.1016\/j.otc.2023.02.018_bib24","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.1016\/j.scr.2021.102474","article-title":"Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation","volume":"55","author":"Nourbakhsh","year":"2021","journal-title":"Stem Cell Res"},{"issue":"6","key":"10.1016\/j.otc.2023.02.018_bib25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ajmg.a.62700","article-title":"Analysis of induced pluripotent stem cell clones derived from a patient with mosaic neurofibromatosis type 2","volume":"188","author":"Ishi","year":"2022","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.otc.2023.02.018_bib26","first-page":"734","article-title":"Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand","volume":"27","author":"Malicki","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"issue":"10","key":"10.1016\/j.otc.2023.02.018_bib27","doi-asserted-by":"crossref","first-page":"e13790","DOI":"10.1002\/acm2.13790","article-title":"A\u00a0potential revolution in cancer treatment: A topical review of FLASH radiotherapy","volume":"23","author":"Gao","year":"2022","journal-title":"J\u00a0Appl Clin Med Phys"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1078-0432.CCR-18-1796","article-title":"Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RT","volume":"25","author":"Harrington","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.otc.2023.02.018_bib29","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/mp.15442","article-title":"Ultra-high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigm","volume":"49","author":"Sch\u00fcler","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.otc.2023.02.018_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2019.06.019","article-title":"Treatment of a first patient with FLASH-radiotherapy","volume":"139","author":"Bourhis","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2023.02.018_bib31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fonc.2017.00314","article-title":"Fluorescence-Guided Surgery","volume":"7","author":"Nagaya","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.29891","article-title":"A\u00a0Scoping Review of Ongoing Fluorescence-Guided Surgery Clinical Trials in Otolaryngology","volume":"132","author":"Crawford","year":"2022","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2023.02.018_bib33","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1097\/MAO.0000000000002988","article-title":"Fluorescent Detection of Vestibular Schwannoma Using Intravenous Sodium Fluorescein In\u00a0Vivo","volume":"42","author":"Szczupak","year":"2021","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2023.02.018_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DDDT.S280069","article-title":"A\u00a0Review of Drug Therapy in Vestibular Schwannoma","volume":"15","author":"Long","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.otc.2023.02.018_bib35","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3390\/ijms23105462","article-title":"A\u00a0Critical Overview of Targeted Therapies for Vestibular Schwannoma","volume":"23","author":"Tamura","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.otc.2023.02.018_bib36","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib37","doi-asserted-by":"crossref","first-page":"12922","DOI":"10.1038\/s41598-017-13032-9","article-title":"Tumor-Penetrating Delivery of siRNA against TNF\u03b1 to Human Vestibular Schwannomas","volume":"7","author":"Ren","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-018-2788-6","article-title":"Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors","volume":"138","author":"Wang","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.otc.2023.02.018_bib39","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3389\/fimmu.2019.02250","article-title":"Engineered T Cell Therapy for Cancer in the Clinic","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.018_bib40","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1038\/s41467-019-13640-1","article-title":"A\u00a0VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2","volume":"10","author":"Tamura","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.otc.2023.02.018_bib41","series-title":"Gene therapy: an Overview of approved and pipeline technologies. In: CADTH Issues in emerging health technologies","first-page":"1","author":"Sinclair","year":"2018"},{"issue":"24","key":"10.1016\/j.otc.2023.02.018_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202719119","article-title":"Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth","volume":"119","author":"Ahmed","year":"2022","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:55:28Z","timestamp":1758466528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666523000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0030666523000403"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2023.02.018","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Future of Vestibular Schwannoma Management","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2023.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}